766 related articles for article (PubMed ID: 26245379)
1. Structural insights into µ-opioid receptor activation.
Huang W; Manglik A; Venkatakrishnan AJ; Laeremans T; Feinberg EN; Sanborn AL; Kato HE; Livingston KE; Thorsen TS; Kling RC; Granier S; Gmeiner P; Husbands SM; Traynor JR; Weis WI; Steyaert J; Dror RO; Kobilka BK
Nature; 2015 Aug; 524(7565):315-21. PubMed ID: 26245379
[TBL] [Abstract][Full Text] [Related]
2. Propagation of conformational changes during μ-opioid receptor activation.
Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
[TBL] [Abstract][Full Text] [Related]
3. Structure of the µ-opioid receptor-G
Koehl A; Hu H; Maeda S; Zhang Y; Qu Q; Paggi JM; Latorraca NR; Hilger D; Dawson R; Matile H; Schertler GFX; Granier S; Weis WI; Dror RO; Manglik A; Skiniotis G; Kobilka BK
Nature; 2018 Jun; 558(7711):547-552. PubMed ID: 29899455
[TBL] [Abstract][Full Text] [Related]
4. Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.
Cheng JX; Cheng T; Li WH; Liu GX; Zhu WL; Tang Y
Acta Pharmacol Sin; 2018 Jan; 39(1):154-164. PubMed ID: 29188799
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
Manglik A; Kruse AC; Kobilka TS; Thian FS; Mathiesen JM; Sunahara RK; Pardo L; Weis WI; Kobilka BK; Granier S
Nature; 2012 Mar; 485(7398):321-6. PubMed ID: 22437502
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
[TBL] [Abstract][Full Text] [Related]
8. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method.
Wang YT; Chan YH
Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303
[TBL] [Abstract][Full Text] [Related]
9. Ligand based conformational space studies of the μ-opioid receptor.
Sena DM; Cong X; Giorgetti A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
[TBL] [Abstract][Full Text] [Related]
10. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.
Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK
Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling of salsolinol, a full G
Berríos-Cárcamo P; Rivera-Meza M; Herrera-Marschitz M; Zapata-Torres G
Chem Biol Drug Des; 2019 Aug; 94(2):1467-1477. PubMed ID: 30920734
[TBL] [Abstract][Full Text] [Related]
12. Structural features of β2 adrenergic receptor: crystal structures and beyond.
Bang I; Choi HJ
Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
[TBL] [Abstract][Full Text] [Related]
13. How μ-opioid receptor recognizes fentanyl.
Vo QN; Mahinthichaichan P; Shen J; Ellis CR
Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
[TBL] [Abstract][Full Text] [Related]
14. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
Noha SM; Schmidhammer H; Spetea M
ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
[TBL] [Abstract][Full Text] [Related]
16. Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72.
Munro TA
BMC Biol; 2023 Oct; 21(1):213. PubMed ID: 37817141
[TBL] [Abstract][Full Text] [Related]
17. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
[TBL] [Abstract][Full Text] [Related]
18. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
19. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
